Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Busulfan, cyclophosphamide, antithymocyte globulin	Busulfan	[3] D00248, D00287, D07760 💬	-	-	[2] 19, 20 💬
2	Busulfan, cyclophosphamide, atg	Busulfan	[3] D00248, D00287, D07760 💬	-	-	[1] 19 💬
3	Busulfan, cyclophosphamide, atg, gcsf	Busulfan	[3] D00248, D00287, D07760 💬	-	-	[2] 65, 284 💬
4	Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen)	Antithymocyte immunoglobulin (rabbit)	[5] D00248, D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 326 💬
5	Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.	Busulfan	[6] D00184, D00248, D00287, D01907, D07760, D07966 💬	[6] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬	[37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[2] 60, 285 💬
6	Campath, fludarabine, cyclophosphamide	Cyclophosphamide	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[2] 65, 284 💬
7	Cyclophosphamide	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
8	Cyclophosphamide (cy)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
9	Cyclophosphamide (cy) (plan 1)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 60, 285 💬
10	Cyclophosphamide (cy) (plan 2)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 60, 285 💬
11	Cyclophosphamide (cytoxan)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 65 💬
12	Cyclophosphamide (drug)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 13 💬
13	Cyclophosphamide + pred	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 283 💬
14	Cyclophosphamide 100mg	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
15	Cyclophosphamide 150mg	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
16	Cyclophosphamide 30	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[3] 65, 285, 326 💬
17	Cyclophosphamide 40	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[3] 65, 285, 326 💬
18	Cyclophosphamide 50mg	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
19	Cyclophosphamide 50mg oral tablet	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 162 💬
20	Cyclophosphamide and atg	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 13 💬
21	Cyclophosphamide and fludarabine	Cyclophosphamide	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 13 💬
22	Cyclophosphamide and steroids	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 222 💬
23	Cyclophosphamide dose level 1	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 65, 284 💬
24	Cyclophosphamide dose level 2	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 65, 284 💬
25	Cyclophosphamide dose level 3	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 65, 284 💬
26	Cyclophosphamide dose level 4	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[2] 65, 284 💬
27	Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids	Azathioprine	[6] D00142, D00238, D00287, D02115, D03033, D07760 💬	[2] DHFR, DHFR2 💬	[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	[1] 44 💬
28	Cyclophosphamide injection 1g	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[3] 50, 51, 52 💬
29	Cyclophosphamide monohydrate	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[4] 13, 60, 96, 256 💬
30	Cyclophosphamide post transplant	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 65 💬
31	Cyclophosphamide(ctx)	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 224 💬
32	Cyclophosphamide, azathioprine,prednisone,methylprednisolone	Azathioprine	[11] D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 42, 43, 45 💬
33	Cyclophosphamide, bortezomib, and dexamethasone (cybord)	Bortezomib	[12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 28 💬
34	Cyclophosphamide, bortezomib, dexamethasone	Bortezomib	[12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 28 💬
35	Cyclophosphamide, bortezomib, dexamethasone plus daratumumab	Bortezomib	[13] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬	[3] CD38, NR3C1, PSMB5 💬	[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia	[1] 28 💬
36	Cyclophosphamide, fludarabine	Cyclophosphamide	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 285 💬
37	Cyclophosphamide, fludarabine , thymoglobulin	Antithymocyte immunoglobulin (rabbit)	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 60 💬
38	Cyclophosphamide, fludarabine, rabbit atg	Antithymocyte immunoglobulin (rabbit)	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 60 💬
39	Cyclophosphamide, fludarabine, thymoglobulin	Antithymocyte immunoglobulin (rabbit)	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 60 💬
40	Cyclophosphamide,campath ih and tbi	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
41	Cyclophosphamide,cyclosporine a	Cyclophosphamide	[3] D00184, D00287, D07760 💬	[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 60 💬
42	Cyclophosphamide-prednisone-azathioprine	Azathioprine	[5] D00238, D00287, D00473, D03033, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
43	Cyclophosphamide/glatiramer acetate	Acetate	[3] D00287, D04318, D07760 💬	[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	[1] 13 💬
44	Fludarabine, cyclophosphamide	Cyclophosphamide	[4] D00287, D01907, D07760, D07966 💬	[1] RRM1 💬	[5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	[1] 60 💬
45	Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 60 💬
46	High-dose cyclophosphamide	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 96 💬
47	Iv cyclophosphamide	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 51 💬
48	Lenalidomide, dexamethasone and cyclophosphamide	Cyclophosphamide	[12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬	[2] NR3C1, TNF 💬	[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 28 💬
49	Prednisone and cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
50	Prednisone plus cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
51	Prednisone, cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 40 💬
52	Prednisone, methylprednisolone,cyclophosphamides	Methylprednisolone	[7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 42, 43, 45 💬
53	Procedure: cyclophosphamide	Cyclophosphamide	[2] D00287, D07760 💬	-	-	[1] 65 💬
54	Rituximab and cyclophosphamide iv	Cyclophosphamide	[3] D00287, D02994, D07760 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 35 💬
55	Thalidomide, cyclophosphamide and prednisone	Cyclophosphamide	[4] D00287, D00473, D00754, D07760 💬	[2] NR3C1, TNF 💬	[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 331 💬

Back to top